10.1002/anie.202002464
Angewandte Chemie International Edition
COMMUNICATION
Co-crystallization induced spontaneous deracemization: A
general thermodynamic approach to deracemization.
Michael Guillot‡, Joséphine de Meester‡, Sarah Huynen‡, Laurent Collard‡, Koen Robeyns‡, Olivier
Riant*, Tom Leyssens*
[*]
Prof. T. Leyssens & Prof O. Riant
Department of Molecular Chemistry, Materials and Catalysis
Institute of condensed Matter and Nanosciences Université Catholique de Louvain
Place Louis Pasteur, 1 bte L4.01.06, BE-1348 Louvain-La-Neuve, Belgium
M. Guillot, J de Meester, S. Huynen, L.Collard, K. Robeyns
[‡]
Department of Molecular Chemistry, Materials and Catalysis
Institute of condensed Matter and Nanosciences Université Catholique de Louvain
Place Louis Pasteur, 1 bte L4.01.06, BE-1348 Louvain-La-Neuve, Belgium
Supporting information for this article is given via a link at the end of the document.
between two diastereomeric salts and does therefore not require
the formation of such a conglomerate.
Abstract: Processes leading to enantiopure compounds are of
utmost importance, in particular for the pharmaceutical industry.
Starting from
a
racemic mixture, Crystallization Induced
theoretical 100%
Diastereomeric Transformation allows for
a
As highlighted by a 2006 literature revue CIDT can only be
performed on salt-forming compounds with the vast majority of
studied systems combining a carboxylic acid with an amine[20]. For
non-salifiable compounds, to the best of our knowledge, no
thermodynamically based deracemization method has been
reported and thus many racemizable compounds are left with no
viable option for deracemization. We are the first, to introduce
here such a method, based on co-crystallization, expanding the
scope of thermodynamically based deracemization processes to
all racemizable compounds (scheme 1). Co-crystallization
typically relies on strong intermolecular interactions like hydrogen
transformation of the desired enantiomer. However, this method has
the inherent limiting requirement for the organic compound to form a
salt. In this contribution, this limitation is lifted by introducing co-
crystallization in the context of thermodynamic deracemization, with
the process applied to a model chiral fungicide. We here report a new
general single thermodynamic deracemization process based on co-
crystallization for the deracemization of (R,S)-4,4-dimethyl-1-(4-
fluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-Pentan-3-one.
This
work
presents the feasibility of this novel approach and paves the way to
further development of such processes.)
or halogen bonding[21]
, which are more universal. Co-
crystallization was recently explored by us and others in the
context of chiral resolution, targeting several racemic drug
systems[22-25]. Based on these methods, and drawing a parallelism
to CIDT, we set out to go beyond chiral resolution targeting a Co-
crystallization Induced Spontaneous Deracemization (CoISD)
process. The process developed here is innovative, industrially
friendly and scope-expanding. It is a thermodynamic process
applicable to all, non-salt as well as salt forming compounds, and
both to conglomerate or racemic compound forming systems,
hereby making it a general process compared to all the other
crystallization based deracemization processes.
With the increasing number of enantiopure chiral drugs
developed every year[1] and regulatory instances encouraging the
development of enantiopure compounds[2], processes allowing
access to these, are of utmost importance. In spite of significant
advances in asymmetric synthesis (in particular asymmetric
catalysis), the most prominent way to enantiopure drugs
nowadays still involves formation of a racemic compound[3] and
separation of the unwanted enantiomer through a resolution
process[4-8], or its transformation into the desired enantiomer, in a
so-called
deracemization
process.
Crystallization-based
resolution processes are less costly than eg. chromatographically
based techniques and therefore industrially wide-spread. Typical
crystallization based resolution processes are preferential
crystallization[9-11] and diastereomeric resolution.[12-14] Going
beyond separation, crystallization based deracemization
processes aim at transforming the unwanted enantiomer
(distomer) into the desired one (eutomer). Over the recent years,
different deracemization tools were developed. The kinetic
We used a model system to develop the CoISD process.
The racemic target compound (R,S)-4,4-dimethyl-1-(4-
fluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-Pentan-3-one [RS-BnFTP]
belongs to a family of fungicidal compounds[26], for which a
conglomerate forming system has already successfully been
deracemized through the kinetic Viedma ripening procedure.[27,28]
Combining BnFTP with the chiral co-former, S-3-Phenylbutyric
acid (S-PBA), a diastereomeric pair of co-crystals can be obtained.
Each diastereomer crystallizes in a chiral space group with the
asymmetric unit only containing one enantiomer of the target
compound alongside S-PBA[23,25,29]. The diastereomers crystallize
in the P212121 and P21 space groups for [(S)-BnFTP-(S)-3-
Phenylbutyric acid] (fig. 1.A) and [(R)-BnFTP-(S)-3-Phenylbutyric
acid] (Fig. 1.B) respectively. The former will be referred to as the
(S,S)-co-crystal and is the energetically favored diastereomer1.
process of Viedma Ripening (VR) [15,16] and Dynamic Preferential
[17]
Crystallization (DPC)
require a conglomerate forming
racemate and are therefore inherently limited to 5-10% of all
compounds. Crystallization Induced Diastereomeric
Transformation--CIDT[18,19]
on the other hand, is
,
a
thermodynamical approach, based on the differences in solubility
1 When mixing both racemic RS-BnFTP and RS-PBA, a mixture of the (R,R)
and (S,S) co-crystals are formed instead of the (R,S) – (S,R) mixture, showing
a higher stability of the (S,S) with respect to the (R,S) diasteriomer.
1
This article is protected by copyright. All rights reserved.